These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 18487563

  • 1. Problems and solutions in the evaluation of hormone receptors in breast cancer.
    Allred DC.
    J Clin Oncol; 2008 May 20; 26(15):2433-5. PubMed ID: 18487563
    [No Abstract] [Full Text] [Related]

  • 2. Hormone receptors in breast carcinomas.
    Mandal AK.
    Indian J Pathol Microbiol; 1995 Jan 20; 38(1):109-18. PubMed ID: 8919478
    [No Abstract] [Full Text] [Related]

  • 3. [Hormone treatment of breast cancer].
    Gröhn P.
    Duodecim; 1991 Jan 20; 107(8):603-10. PubMed ID: 1364913
    [No Abstract] [Full Text] [Related]

  • 4. Measurement of ER and PR status in breast cancer using the QuantiGene2.0 assay.
    Chae BJ, Bae JS, Yim HW, Lee A, Song BJ, Jeon HM, Chun MH, Jung SS.
    Pathology; 2011 Apr 20; 43(3):248-53. PubMed ID: 21436635
    [Abstract] [Full Text] [Related]

  • 5. [Hormonal and genotoxic aspects of BRCA1-associated carcinogenesis].
    Bershteĭn LM.
    Vopr Onkol; 2007 Apr 20; 53(6):642-53. PubMed ID: 18416131
    [No Abstract] [Full Text] [Related]

  • 6. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
    De Maeyer L, Van Limbergen E, De Nys K, Moerman P, Pochet N, Hendrickx W, Wildiers H, Paridaens R, Smeets A, Christiaens MR, Vergote I, Leunen K, Amant F, Neven P.
    J Clin Oncol; 2008 Jan 10; 26(2):335-6; author reply 336-8. PubMed ID: 18182677
    [No Abstract] [Full Text] [Related]

  • 7. [Use of polymerase chain reaction (PCR) as an additional diagnostic method in gynecologic oncology].
    Czerwenka KF, Zeillinger R, Kury F, Manavi M, Speiser P, Peschke M, Steinhart U, Hosmann JW, Kubista E.
    Gynakol Rundsch; 1991 Jan 10; 31 Suppl 2():378-9. PubMed ID: 1686430
    [No Abstract] [Full Text] [Related]

  • 8. [Determination of estrogen and progesterone receptors in cancer of the breast. Frequency of presentation and prognostic significance].
    Expósito J, Olea N, Ruiz de Almodovar JM, Pedraza V.
    Rev Esp Oncol; 1985 Jan 10; 32(3):471-85. PubMed ID: 3870538
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
    Badve SS, Baehner FL, Gray RP, Childs BH, Maddala T, Liu ML, Rowley SC, Shak S, Perez EA, Shulman LJ, Martino S, Davidson NE, Sledge GW, Goldstein LJ, Sparano JA.
    J Clin Oncol; 2008 May 20; 26(15):2473-81. PubMed ID: 18487567
    [Abstract] [Full Text] [Related]

  • 11. Cancer is heterogeneous.
    Guinebretiere JM.
    J Clin Oncol; 2009 Jun 01; 27(16):2732; author reply 2734-5. PubMed ID: 19380436
    [No Abstract] [Full Text] [Related]

  • 12. Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.
    Mehta RS.
    J Clin Oncol; 2008 Jul 01; 26(19):3286-8; author reply 3288. PubMed ID: 18591566
    [No Abstract] [Full Text] [Related]

  • 13. Macromolecular binding of dexamethasone as evidence for the presence of mineralocorticoid receptor in human breast cancer.
    Martin PM, Rolland PH, Raynaud JP.
    Cancer Res; 1981 Mar 01; 41(3):1222-6. PubMed ID: 6780185
    [No Abstract] [Full Text] [Related]

  • 14. Biochemical basis of breast cancer treatment by androgens and progestins.
    Rochefort H.
    Prog Clin Biol Res; 1984 Mar 01; 142():79-95. PubMed ID: 6538685
    [No Abstract] [Full Text] [Related]

  • 15. Changing concepts of hormone receptor-positive advanced breast cancer therapy.
    Chlebowski RT.
    Clin Breast Cancer; 2013 Jun 01; 13(3):159-66. PubMed ID: 23228361
    [No Abstract] [Full Text] [Related]

  • 16. The precarious path to diagnostic accuracy: the Ontario hormone receptor guideline.
    Hughes-Davies L.
    Clin Oncol (R Coll Radiol); 2012 Dec 01; 24(10):682-3. PubMed ID: 23031346
    [No Abstract] [Full Text] [Related]

  • 17. Hormone receptors in the management of breast cancer.
    Osborne CK.
    Tex Med; 1984 Nov 01; 80(11):30-2. PubMed ID: 6515569
    [No Abstract] [Full Text] [Related]

  • 18. A case of colonic metastasis of breast cancer positive for estrogen receptor.
    Kamitani S, Fuchimoto S, Naomoto Y, Gohchi A, Matsuda T, Orita K.
    Hiroshima J Med Sci; 1987 Jun 01; 36(2):163-7. PubMed ID: 2820904
    [No Abstract] [Full Text] [Related]

  • 19. [Change in the level of steroid hormone receptors in the tumors of patients with breast cancer complicated by liver and bile duct diseases].
    Portnoĭ SM, Smirnova KD, Bassalyk LS, Murav'eva NI, Kuz'mina ZV.
    Vopr Onkol; 1985 Jun 01; 31(1):55-9. PubMed ID: 3976195
    [Abstract] [Full Text] [Related]

  • 20. Estrogen and progesterone receptor structure and action in breast cancer cells.
    Bettuzzi S, Robinson A, Fuchs-Young R, Greene GL.
    Cancer Treat Res; 1992 Jun 01; 61():301-15. PubMed ID: 1360239
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.